Personalised Medicine Approaches in Scleroderma, Raynaud's, Dr. Corrado Campochiaro, Honorary Clinical Fellow in Rheumatology, Royal Free Hospital – UCL London. Autoimmune Rare Disease.

Personalised Medicine Approaches in Scleroderma, Raynaud's.

Autoimmune Rare Disease.

Dr. Corrado Campochiaro,

Honorary Clinical Fellow in Rheumatology,

Royal Free Hospital – UCL London.

 

The final presentation held at the annual family day 2017, held last week, was that given by Dr. Corrado Campochiaro: 

Personalised Medicine Approaches in Scleroderma

Dr Campochiaro provided a complete and thorough overview as to the current understanding of the enigma, autoimmune rare disease, scleroderma. 

He went into detail explaining the current understanding as to the biological markers which are prevalent for a diagnosis, along with gene expression for such. 

He then went on to detail the current approaches being utilised for treatment approaches as well as research interests. 

Current research includes:

Fold change in gene expression in early compared to late systemic sclerosis patients.

Biological phenotyping of Systemic Sclerosis (BIOPSY) Study

c.campochiaro@ucl.ac.uk

To view the full presentation, Click here  

To view the other presentations from the day, Click here  

Follow the Scleroderma Unit Facebook Page here

BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs, Raynaud's, Scleroderma, Rare Disease, Click here  

EULAR guidelines for treatment of systemic sclerosis, scleroderma, Click here

May 2017. 

To read my articles: 

Rare Disease Day 2018, Research - Taking Part in Clinical Trials, Click here   

March Autoimmune Disease Awareness Month 2018, Click here   

Global patient video, Click here   

Becoming a Patient Research Ambassador for the NIHR, Click here  

If we only had more RESEARCH investment for Scleroderma, Raynaud's, Autoimmune Rare Disease, Click here   

The Importance of Medical Research and Awareness to the Scleroderma, Raynaud's, Autoimmune Rare Disease patient, Click here   

Scleroderma Awareness Month 2017 Patient Profiles Campaign, Click here     

 

Scleroderma Awareness Month 2017 Patient Profiles Campaign Patient Index, Click here        

The Pandora’s Box of the rare autoimmune disease Scleroderma, Raynaud's and Cancer, Click here

Key Event Dates 2018, Click here     

Importance of an Early Diagnosis, Click here     

Taking Part in Clinical Research Trials, Click here   

The Importance of a Multi Disciplinary Medical ‘Dream Team’, Click here 

Expert Specialist Centres, Click here      

My Skin is Cured from Scleroderma, Click here      

UK Guidelines for Managing and Treating Scleroderma, Click here      

Fatigue, Click here      

Mobility, Click here    


Diet and nutrition, Click here     

Raynaud's, Click here  
   

World Scleroderma Day 29^th June 2016, Click here

World Scleroderma Day 29^th June 2017, Click here   


Why Global Collaboration is important to the Rare Disease Patient, Click here      

RARE DISEASE DAY:

The theme to this years Rare Disease Day is Research

Rare Disease Day 2018 – Research, Taking Part in Clinical Trials. Scleroderma, Raynaud's, Autoimmune Rare Disease, Click here     

2016 Rare Disease Day Patient Voice

2016 Rare Disease UK Parliamentary Reception   


2017 Rare Disease Day Flashback  

2017 Rare Disease Day unmet clinical needs to the scleroderma patient

  

Rare Disease Day is a fantastic opportunity for the entire rare disease community to shine a spotlight on their reality, combining as one unified voice. Where, at least one commonality presides –  

Medical Research provides the brightest light

for the illumination of the rare disease patients’ plight. 

I highlighted other areas of medical research interest within Week 3 of my Patient Profiles Campaign for Scleroderma Awareness Month 2017. 

VIDEO

INDEX

Although rare disease patients are few in number, eg. 2.5 million scleroderma patients worldwide, (the World Scleroderma Foundation), the commonalities and golden hallmark for each rare disease patient are the same: 

Early Diagnosis

Expert Specialist Centres

Access to Innovative Medicines

Where MEDICAL RESEARCH investment is VITAL.

Research is the key. Abstracts from 2016 World Congress, Click here

Scleroderma Awareness Month Campaign 2016, Click here

Links

View video, here   

Preamble - here

The Family Day at the Scleroderma Unit, The Royal Free Hospital is taking place on the 19^th May 2018. Browse the program, here

This year, I am celebrating 20 years of being a patient at this world leading expert specialist research centre. 

Sept 2017

I am eternally grateful to the global scleroderma trail blazers Dame Prof Black and Prof Chris Denton, whose commitment and dedication to unlocking the scleroderma enigma, is nothing other than, superhuman.

I am truly humbled and inspired by their work ethic. I am wholly appreciative for Prof Denton’s continued medical expertise and support, especially during my barrister qualifying years, 1997 - 2004. 

1^st March 2004, I qualified as a self employed practising barrister. Further to having been told in 1997, by my diagnosing doctor, that I was looking at a 15month prognosis. 

I very much hope to utilise my professional skills and qualifications along with my patient experience, to help achieve the #SclerodermaFreeWorld dream, hoping to improve understanding and best practice, in the meantime.

  

For latest updates follow: 

Facebook Page:

Raynauds Scleroderma Awareness Global Patients

Twitter: @SclerodermaRF  @RaynaudsRf  

Google Plus:  Raynauds Scleroderma Awareness Global Patients  

#SclerodermaFreeWorld           #RaynaudsFreeWorld

#ADAM #Scleroderma

#Raynauds

#RareDisease  

Living the dream, scleroderma style.  

Please DONATE to help fund medical research at The Scleroderma Unit,The Royal Free Hospital, London.  

100% of your monies will be used for medical research purposes only. No wages or admin costs. Thank You.

#HOPE 

 

Last Update: April 2018